Sun Pharmaceutical Quarterly Results for Trading Insights
SUNPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹3,125 Cr
QSept 2025
Sun Pharmaceutical Quarterly Results Key Highlights
- Revenue of ₹14,875 Cr in Sept 2025 (+10.8% vs Mar 2025, +9.2% vs Sept 2024)
- Net Profit of ₹3,125 Cr in Sept 2025 (+45.1% vs Mar 2025, +2.9% vs Sept 2024)
- EBITDA of ₹4,924 Cr in Sept 2025 (+28.8% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+6.0pp vs Mar 2025)
- Earnings Per Share of ₹13.00 in Sept 2025 (+44.4% vs Mar 2025)
Sun Pharmaceutical Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 14,875 | 13,429 | 14,251 | 13,618 | 12,419 | 10.8% | 9.2% |
| Net Profit (₹ Cr) | 3,125 | 2,154 | 2,293 | 3,037 | 2,659 | - | - |
| EBITDA (₹ Cr) | 4,924 | 3,824 | 3,883 | 4,266 | 3,370 | - | - |
| EPS (₹) | 13.00 | 9.00 | 9.50 | 12.70 | 11.10 | - | - |
| Operating Margin (%) | 31.0% | 25.0% | 25.0% | 29.0% | 23.0% | - | - |
Sun Pharmaceutical Share Price Trend Around Quarterly Results
Visualize Sun Pharmaceutical's 1-year price movement across quarterly results — ideal for logging trades in Sun Pharmaceutical share price
chart using Tickjournal. All values in ₹.
Related Pages for Sun Pharmaceutical
Additional stock information and data for SUNPHARMA
Revenue Trend (₹ Cr)
Sept 2024
13,618
Jun 2025
14,251
Mar 2025
13,429
Sept 2025
14,875
Net Profit Trend (₹ Cr)
Sept 2024
3,037
Jun 2025
2,293
Mar 2025
2,154
Sept 2025
3,125
Operating Margin Trend (%)
Sept 2024
29.0%
Jun 2025
25.0%
Mar 2025
25.0%
Sept 2025
31.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Sun Pharmaceutical quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
|
Lupin
Sept 2025 |
₹100,719.57 Cr | 2149.7 | 6,921 | 1,485 | +23.2% | - | 21.5% | 66.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores